If you have used Bextra as directed by a doctor and suffered a heart attack, stroke, or serious skin reactions, you may be entitled to compensation.
Use of Bextra has been shown to produce higher than normal cardiovascular events for patients. This includes heart attacks and strokes. It has also been linked to potentially life threatening skin conditions including Stevens Johnson Syndrome, toxic epidermal necrolysis, and erythema multiforme.
Bextra is prescription drug used to treat arthritis, menstrual cramps, and associated problems. It is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and helps reduce pain, swelling, and fever without causing stomach irritation.
On April 7, 2005, Pfizer removed Bextra from the market in response to pressure from the FDA.
Bextra (valdecoxib) is a non-steroidal anti inflammatory drug. It was approved for use in the United States for treating arthritis pain and severe menstrual cramps in November 2001. Several reports of side effects indicate that Bextra users are at an increased risk for serious skin conditions, including Stevens Johnson Syndrome, toxic epidermal necrolysis (TEN), and erythema multiforme (EM).
Bextra Side Effects
Stevens Johnson Syndrome is a rare inflammatory skin disorder that can be fatal in severe cases. Studies have also suggested that Bextra may be linked to an increased risk of heart attacks and strokes. Patients who have suffered serious medical problems after taking Bextra may be eligible to file a lawsuit and collect compensation for their damages and losses.